https://www.cardiolrx.com/cardiol-therapeutics-achieves-target-patient-enrollment-in-its-phase-ii-archer-trial-investigating-cardiolrx-for-acute-myocarditis/
https://ir.altimmune.com/news-releases/news-release-details/altimmune-completes-enrollment-phase-2b-impact-trial-pemvidutide
https://www.capricor.com/investors/news-events/press-releases/detail/291/capricor-therapeutics-announces-intent-to-file-biologics
Piper Sandler Proprietary Report on ALT
